Cholesterol Lowering Drugs: AKA Statins
In 2008, BusinessWeek published an article questioning whether statins were being prescribed too broadly. At the time, debate centered on who should receive treatment, the magnitude of benefit in lower-risk individuals, and concerns about adverse effects. Those discussions helped spur additional research and continue to influence conversations about individualized cardiovascular risk assessment today.
In 2008 Business Week published an article questioning the value of statins
